I think describing your analysis as pathetic is a little self-flagellating - it's a legitimate question to ask whether MCE will get back to generating sustainable positive cash flows. The last 3 or so years haven't been pretty (in fact, they've been downright terrible) but i think they have to be viewed in the relevant context, i.e. the most severe and protracted downturn in oil capex (and particularly offshore oil capex, MCE's market) in 30+ years.
My personal view is that 2H17 will mark the nadir of MCE, given that 1H18 showed tentative signs of improvement (no more restructures/redundancies, small revenue improvement and smaller EBITDA loss), and they've got US$19m orders to support FY19/20...but it's still a very long back to the glory days of $20m+ EBITDA.
- Forums
- ASX - By Stock
- Ann: Investor Presentation Dec 17 Half Year Results
I think describing your analysis as pathetic is a little...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.055(23.9%) |
Mkt cap ! $72.45M |
Open | High | Low | Value | Volume |
26.0¢ | 29.0¢ | 26.0¢ | $30.18K | 106.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 80000 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 127951 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14995 | 0.290 |
1 | 8500 | 0.285 |
1 | 6500 | 0.280 |
1 | 15000 | 0.270 |
1 | 10000 | 0.265 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 3031 | 1 |
0.340 | 3649 | 1 |
0.345 | 12762 | 1 |
0.350 | 98847 | 3 |
0.360 | 30000 | 1 |
Last trade - 14.39pm 25/11/2024 (20 minute delay) ? |
Featured News
MCE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online